This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Biomarin Pharmaceutical Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Todd M Oppeneer: Innovator in Osteoarthritis Treatment
Introduction
Todd M Oppeneer is a notable inventor based in Novato, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of osteoarthritis. With a total of 2 patents to his name, Oppeneer's work focuses on innovative therapeutic approaches that aim to improve patient outcomes.
Latest Patents
Oppeneer's latest patents include the use of C-type natriuretic peptide variants to treat osteoarthritis. The disclosure relates to the use of these variants to ameliorate one or more symptoms of osteoarthritis and to treat disorders that have an osteoarthritis component. This innovative approach highlights his commitment to advancing medical treatments and improving the quality of life for individuals suffering from this condition.
Career Highlights
Todd M Oppeneer is currently associated with BioMarin Pharmaceutical Inc., where he continues to work on groundbreaking research and development projects. His expertise in the field has positioned him as a valuable asset to the company and the broader medical community.
Collaborations
Some of his notable coworkers include Charles A O'Neill and Jason K Pinkstaff. Their collaborative efforts contribute to the innovative environment at BioMarin Pharmaceutical Inc., fostering advancements in medical research.
Conclusion
In summary, Todd M Oppeneer is a distinguished inventor whose work in osteoarthritis treatment is paving the way for new therapeutic options. His contributions to the field are significant and reflect his dedication to improving patient care.